During the past decade, Norris Healthcare Center 3 (HC3) conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norris Healthcare Center 3 (HC3)" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Pierre Fabre Medicament" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Norris Healthcare Center 3 (HC3)" are "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials), "Brain Neoplasms" (1 trials), "Brain Neoplasms, Primary" (1 trials), "Breast Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Norris Healthcare Center 3 (HC3)" in a lesser frequency.

Most popular intervention types in "Norris Healthcare Center 3 (HC3)" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Binimetinib" (2 trials), "5-Fluorouracil" (1 trials), "Cetuximab" (1 trials), "Encorafenib" (1 trials) and "Folinic Acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Norris Healthcare Center 3 (HC3)" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Norris Healthcare Center 3 (HC3)". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Norris Healthcare Center 3 (HC3), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Norris Healthcare Center 3 (HC3), 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".